Fluoxetine Does Not Worsen Sleep Apnoea
Fluoxetine is actually listed as a weight-neutral alternative to other antidepressants that may worsen obstructive sleep apnoea through weight gain, and has been studied as a potential treatment agent for OSA rather than a worsening factor 1.
Evidence from Guidelines
The 2017 British Journal of Pharmacology guideline on medications and OSA explicitly categorizes fluoxetine as a possible alternative to paroxetine in the selective serotonin reuptake inhibitor (SSRI) class when weight gain is a concern 1. The guideline identifies drugs that worsen sleep apnoea through specific mechanisms:
- Direct respiratory depression: Opioids, benzodiazepines
- Muscle relaxation: Baclofen and myorelaxants
- Hormonal effects: Testosterone
- Weight gain: Various psychotropics including paroxetine (but NOT fluoxetine)
Fluoxetine appears in Table 2 of this guideline under "Possible alternatives" specifically because it avoids the weight gain associated with paroxetine 1.
Clinical Trial Evidence
Rather than worsening OSA, fluoxetine has been investigated as a potential therapeutic agent:
A 1991 randomized trial compared fluoxetine to protriptyline in 12 OSA patients and found fluoxetine significantly decreased REM sleep proportion and reduced apneas/hypopneas in NREM sleep, with better tolerability than protriptyline 2
A 2010 prospective trial tested fluoxetine combined with ondansetron and demonstrated approximately 40% reduction in AHI at days 14 and 28, with improved oximetry trends 3
The mechanism involves serotonin's role as a central respiratory stimulant and its effect on upper airway dilator muscle tone 4
Important Clinical Caveat
While fluoxetine does not directly worsen OSA, one observational study found that antidepressant exposure (measured in total fluoxetine units and treatment duration) was associated with higher risk of metabolic syndrome in patients with major depressive disorder and OSA 5. This represents an indirect association through metabolic pathways rather than direct worsening of sleep-disordered breathing.
Practical Recommendation
If you need to prescribe an SSRI to a patient with known or suspected OSA, fluoxetine or sertraline are preferred over paroxetine due to their weight-neutral profiles 1. Avoid benzodiazepines, opioids, and sedating medications that directly suppress respiratory drive or upper airway muscle tone 1.
The 2013 American College of Physicians guideline notes that pharmacologic therapy for OSA treatment showed insufficient evidence, but this refers to using drugs as primary OSA treatment, not to drugs worsening the condition 6.